Name: HEALTHCHECK DIAGNOSTICS, INC.

Official Site: http://healthchecktech.com

HealthCheck Diagnostics offers a new test that accurately predicts atherosclerosis and heart attacks. Doctors estimate up to 70% of people over 40 have coronary artery disease (CAD), but the disease is sub-clinical (no physical symptoms). HealthCheck Diagnostics draws on the immune response created by atherosclerotic disease. Tests use enzyme-linked immunosorbent assay (ELISA) plates coated with specific isotypes.

Key Benefits:

• Get results in less than 24 hours
• The anti-MAA biomarkers nearly double between the control group and the atherosclerosis group with stable CAD which makes it easy to see who is in danger
• Until now, there has been no non-invasive test to identify these CAD individuals

Visit http://healthchecktech.com to learn more about this disruptive technology.

Name: RETRIEVE MEDICAL

Official Site: https://retrievemedical.com/

US hospitals are losing millions each year due to underpaid billings from Medicare and Medicaid as a result of inadequate coding of patient data. Retrieve Medical has developed a software technology that has been fully proven in Stony Brook Hospital to save hospitals over $4 million a year from increased documentation efficiencies. The technology is also proven to potentially increase documented diagnoses by 75%. Additionally, the technology has shown to significantly increase CMI accuracy as well as decrease the amount of time necessary to identify a comorbidity by 1/3. Hospitals are especially focused on CMI numbers due to heavy penalties from Medicare and Medicaid.

Key Benefits:

• Save hospitals up to $5 million a year from increased documentation efficiencies
• 75% more diagnoses when compared to using physician documentation alone
• 1/3 the amount of time necessary to identify a comorbidity
• Significant reduction in O/E mortality rates
• Increased accuracy of CMI resulting in additional revenue
• Easily implemented directly within your current EHR system

Visit https://retrievemedical.com to learn more about this technology.

Name: AUTISM DIAGNOSTIC TECHNOLOGIES, INC.

Official Site: http://autismdiagnostictechnology.com

There is an estimated 3.5 million Americans living with Autism Spectrum Disorder (ASD). The Center for Disease Control recommends all children be screened for developmental delays and disabilities at 18 and 24 months. However, the average age of diagnosis for autism spectrum disorder (ASD) in the US is still around 4 years of age. ADT’s disruptive technology has been proven to diagnose autism in infants as young as six months old at a >90% rate of accuracy. Three scientific studies have recently shown that with early diagnosis of ASD, when the child’s brain is more malleable and still developing circuitry, treatment can begin with increased positive outcomes.

Research Scientists have developed a method of mapping brains using current technologies combined with a unique invention to compare normal brains to autistic, dyslexic, and Alzheimer’s affected brains.

Key Benefits:

• 90%+ accuracy diagnosis of ASD as early as 6-months old
• Technology can be expanded for use with other brain disorders and disease

Visit http://autismdiagnostictechnology.com to learn more about this technology.

Name: ENHANCED PLASMONIC IMAGING, INC.

Official Site: http://epimaging.com

Overview: Enhanced Plasmonic Imaging offers a novel way to detect minute amounts of bacteria and chemicals for researchers, labs, and governments’ facilities. This technology provides a novel nano-grating structure that uses a more efficient and cost-effective surface patterning process. Instead of expensive traditional e-beam lithography techniques, this technology uses plasmonic gratings fabricated as soft/hard hybrid nano-structures. Graded nano structures produced enhancements 47 times better than flat gold.

Key Benefits:

• Nanocone and nanogap gratingstructure offers up to 47 times enhancement over flat gold. Increases image contrast and detection.
• Fluorescence enhancement allows lower intensity lighting to give the same or better strength signal as high-intensity illumination.
• Detects quantities as small as a single particle
• DNA detection at levels that negate the need for Polymerase Chain Reaction(PCR).
• Existing fluorophores used– no new ones to develop.
• Virus and bacteria identification without need for culturing for tests such as PSA (prostate specific antigen), tuberculosis, and breast cancer markers.
• No probe needed to obtain images so the technology does not distort the local environment. It maintains a high level of imaging accuracy.
• Images the entire sample at one time instead of point-by-point scanning needed to obtain the whole image with near-field scanning microscopy.
• Lower per-unit cost of manufacturing with the potential to drop even further by leveraging methods of manufacturing at scale.

Visit http://epimaging.com to learn more about this technology.

Name: BIO-MEDPOINT INC.

Official Site: http://biomedpointsolutions.com

Coronary Artery Disease (CAD) kills 370,000 Americans and costs the US $109 Billion each year. Currently the only way to predict a patient’s likelihood of getting heart disease is by patient history, or the Framingham Risk Score (FRS) which estimates the chances a person will have a cardiac event in the next 10 years. Unfortunately, these tests have low accuracy. There is a strong need for an improved CAD diagnostic test. Bio-MedPoint’s disruptive diagnostic has proven to be 94% accurate in identifying patients with CAD, compared to a 42% accuracy with the FRS.

Key Benefits:

• Bio-Medpoint’s algorithms not only show evidence of the disease, they also indicate varying degrees of disease— from healthy to high probability of CAD
• 100% more accurate than Framingham Risk Score at predicting CAD
• Technology can leverage existing laboratory machines as retrofit module
• Requires only a small sample of blood serum
• Opportunity for significant margins – approximately $7 to run each blood sample

Visit http://biomedpointsolutions.com to learn more about this technology.

Name: SLIM HEALTH PET FOOD, INC.

Official Site: http://slimhealthpets.com

Slim Health is the only food formula whereby the more that you or your furry companion eats, the more weight lost. According to 2018 data, the obesity epidemic extends to our pets with 56% of dogs and 60% of cats overweight in the US. As such we will be moving into the pet food market first in 2019 focusing upon dogs with a future product line formulated for cats. Our formula can easily be applied to human food as well and as such we are eyeing a 2021 launch for our human food lines.

Key Benefits:

• The more of our formula eaten, the greater the increase in metabolism and the less fat stored
• Projected pricing in line with other premium pet foods
• No need to change diet, routine, or restrict calories

Visit http://slimhealthpets.com to learn more about this disruptive technology.

Name: DREAM BODY SYSTEM, INC.

Official Site: https://dreambodysystem.com

Dream Body System (DBS) is a new patented weight loss method. One that has been proven effective in more than 20,000 patients. This is a different way to lose weight that will help patients achieve their weight loss goal without drugs, hunger, or invasive, risky surgery. Our clinical study on 281 patients was peer reviewed and the results have been verified. Our average patient lost 12.8 pounds in just 10 days.

Key Benefits:

• Rapid Weight Loss – average of 1 – 2 pounds lost each day
• No Willpower Required
• No Hunger
• No Drugs or Surgery

Visit www.dreambodysystem.com to learn more about this technology.

Name: LEGEND LABZ, INC.

Official Site: https://legendlabz.com

• Shown to increase muscle mass gains by 200%
• 20 times more effective than Creatine
• 10 times more effective than Amino Acids
• All Natural, plant derived ingredients
• No testosterone boosters or harmful substances

Visit www.legendlabz.com to learn more about this technology.